The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experience
While first-line induction therapy for patients with multiple myeloma has changed over the years, autologous hematopoietic stem cell transplantation still plays a significant role, improving both depth of response and progression-free survival of myeloma patients. Our 25-year experience in mobilizin...
Main Authors: | Amarilis Figueiredo, Rabih Kassis, Rashed Albacker, Arleigh McCurdy, Natasha Kekre, Harold Atkins |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137919300884 |
Similar Items
-
The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences
by: Cheryl Pritlove, et al.
Published: (2021-07-01) -
Anaplastic large cell lymphoma as a posttransplant lymphoproliferative disorder in a renal transplant patient: A case report
by: Manar Alabdulbaqi, et al.
Published: (2020-07-01) -
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis
by: Owais Mian, et al.
Published: (2023-01-01) -
A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells
by: Nathan J. Fergusson, et al.
Published: (2023-04-01) -
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database
by: Arleigh McCurdy, et al.
Published: (2022-03-01)